Agile Therapeutics
AGRX
$0.40
Share price
0.00%
Change (1 day)
-93.94%
Change (1 year)
Categories
Agile Therapeutics (AGRX) - Total debt
Total debt on the balance sheet as of September 2023 : $2.51 M
According to Agile Therapeutics 's latest financial reports the company's total debt is $2.51 M. A company’s total debt is the sum of all current and non-current debts.
Agile Therapeutics - Total debt on balance sheet (from 2013 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $2.21 M | -87.57% |
| 2021-12-31 | $17.79 M | 7.71% |
| 2020-12-31 | $16.51 M | 9504.07% |
| 2019-12-31 | $0.17 M | |
| 2017-12-31 | $10.6 M | -32.49% |
| 2016-12-31 | $15.71 M | 3.14% |
| 2015-12-31 | $15.23 M | 2.7% |
| 2014-12-31 | $14.83 M | -0.3% |
| 2013-12-31 | $14.87 M | 0.59% |
| 2012-12-31 | $14.78 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 1,165,255.58% | 🇺🇸 USA |
 Pfizer PFE | $70.84 B | 2,814,560.31% | 🇺🇸 USA |
 Merck MRK | $35.05 B | 1,392,629.44% | 🇺🇸 USA |
 TherapeuticsMD TXMD | $8.2 M | 225.94% | 🇺🇸 USA |
 Antares Pharma ATRS | N/A | N/A | 🇺🇸 USA |